Clinical Trials Directory

Trials / Unknown

UnknownNCT04106518

Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
447 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Alcoholic hepatitis carries a risk of high mortality at short term, especially in its severe form. Its diagnosis is confirmed by liver biopsy. The prevalence of alcoholic hepatitis, severe or not severe, is poorly known and prospective data are needed. The present observational study aims to define the prevalence of alcoholic hepatitis among patients admitted for jaundice and determine their outcome according to the severity. Survival and markers of liver dysfunction will be assessed. A biobank including genetic samples will be created to identify the disease profile in terms of inflammation and regeneration. The performance of non-invasive criteria for diagnosis will also be studied.

Conditions

Timeline

Start date
2019-10-23
Primary completion
2025-04-01
Completion
2025-04-01
First posted
2019-09-27
Last updated
2023-11-29

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04106518. Inclusion in this directory is not an endorsement.